Skip to main content
Premium Trial:

Request an Annual Quote

Pronota CEO Resigns as Firm Raises $4.9M

NEW YORK (GenomeWeb News) – Belgian protein diagnostic firm Pronota recently announced the closing of a Series C financing round that raised €3.7 million ($4.9 million).

The company also announced Nick McCooke has resigned as its CEO and as a board member.

The financing will go toward the completion of protein biomarker studies in support of the company's programs for the development of preeclampsia, ovarian cancer, sepsis, and cardio-renal products. Participants in the round included existing investors LSP; Gimv; Biotech Fund Flanders; KBC Private Equity; Johnson & Johnson Development; VIB; MP Healthcare, MedSciences Capital; and a company founder.

Pronota raised €7.9 million in a Series B round in 2010.

The company also said that McCooke has left the company after six years as CEO in order to pursue opportunities closer to his UK home base. Prior to joining Pronota, McCooke had been the CEO of Solexa.

He is being replaced by Katleen Verleysen, who had been Pronota's COO.

Also, John Berriman is stepping down as chairman of the board and being replaced by Rudy Dekeyser, managing director at VIB, Pronota said.

The company uses mass spectrometry-based technologies for the discovery and validation of biomarkers for diagnostic purposes.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.